Thu, Jan 04, 2024
Icra said it foresees research and development expenses for its sample set of companies to stabilise at 6.5-7 per cent of their revenues as they will optimise spending, focusing more on complex molecules and specialty products against plain vanilla generics.
More >
Tue, Nov 28, 2023
The pharmaceutical sector in India is expanding at a remarkable rate, as demonstrated by the 8 per cent year-to-date increase in exports and the noteworthy 29 per cent surge in October alone, according to Veeramani S. V., Chairman of PharmExcil (Pharmaceuticals Export Promotion Council of India).
Tue, Nov 14, 2017
Profit came in at 9.12 billion rupees ($139.48 million) in the quarter ended Sept. 30, compared with 22.35 billion rupees a year ago, the company said.
Mon, Jun 05, 2017
It has been a long and dreary quarter for pharmaceutical companies in Q4 wherein most posted a decline in net profit and things are not looking too good for the Indian pharma companies in the first half of FY18 as well.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
